SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001694665-23-000163
Filing Date
2023-10-17
Accepted
2023-10-17 07:05:54
Documents
13
Period of Report
2023-10-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K evlo-20231017.htm   iXBRL 8-K 28424
5 evlo-20231017_g1.jpg GRAPHIC 7885
  Complete submission text file 0001694665-23-000163.txt   181876

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20231017.xsd EX-101.SCH 1905
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20231017_lab.xml EX-101.LAB 24833
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20231017_pre.xml EX-101.PRE 13049
7 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20231017_htm.xml XML 2836
Mailing Address ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 231328442
SIC: 2834 Pharmaceutical Preparations